Company Announcement Oncology Venture Publishes Q1 2020 Report for the Period January – March 2020

by NASDAQ Market News May 29, 2020

NASDAQ Market News
Click here to email author

CHMP recommends EU approval of Roche’s Rozlytrek for people with NTRK fusion-positive solid tumours and for people with ROS1-positive, advanced non-small cell lung cancer

Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations

Ads